Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


510(k) for Nidek:

This article was originally published in Clinica

Executive Summary

The FDA has given Nidek approval to sell and distribute its MC-7000 multi-wavelength ophthalmic laser system worldwide. The device uses one single laser system to treat glaucoma, age-related-macular-degeneration and retinal disease. Its small size allows the system to be used in the physician's office, clinic and surgical theatre. It can be combined with the YC-1300 or YC-1400 Nd:YAG lasers.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts